About CancerIQ
CancerIQ is a company based in Chicago (United States) founded in 2013. It operates as a SaaS (Software-as-a-Service), and HealthTech. CancerIQ has raised $23.87 million across 6 funding rounds from investors including Amgen, McKesson and Decathlon Capital Partners. The company has 78 employees as of December 31, 2022. CancerIQ offers products and services including CancerIQ Platform and Telehealth Genetic Counseling. CancerIQ operates in a competitive market with competitors including Tempus, Personalis, Perthera, LinkDoc and Trapelo, among others.
- Headquarter Chicago, United States
- Employees 78 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Canceriq, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.87 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
Amgen
& 8 more
-
Employee Count
78
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CancerIQ
CancerIQ offers a comprehensive portfolio of products and services, including CancerIQ Platform and Telehealth Genetic Counseling. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Software for cancer risk assessment and management.
Connects patients to genetic counseling via telehealth.
Unlock access to complete
Funding Insights of CancerIQ
CancerIQ has successfully raised a total of $23.87M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(01 Jun 2013)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series B - CancerIQ | Valuation | Decathlon Capital Partners |
|
| Nov, 2023 | Amount | Series B - CancerIQ | Valuation |
investors |
|
| Mar, 2022 | Amount | Series B - CancerIQ | Valuation | Merck Global Health Innovation Fund , Amgen |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CancerIQ
CancerIQ has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, McKesson and Decathlon Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt funds focused on direct lending, and revenue-based financing
|
Founded Year | Domain | Location | |
|
Corporate-backed venture capital is focused on the life science sector.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CancerIQ
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CancerIQ
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Canceriq Comparisons
Competitors of CancerIQ
CancerIQ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tempus, Personalis, Perthera, LinkDoc and Trapelo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based precision medicine solutions for oncology are provided.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Molecular cancer profiling is conducted via genomics and proteomics.
|
|
| domain | founded_year | HQ Location |
Oncology-focused database is provided for cancer analytics.
|
|
| domain | founded_year | HQ Location |
Precision medicine platform is provided for oncologists' decision support.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Canceriq
Frequently Asked Questions about CancerIQ
When was CancerIQ founded?
CancerIQ was founded in 2013.
Where is CancerIQ located?
CancerIQ is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Who is the current CEO of CancerIQ?
Feyi Olopade is the current CEO of CancerIQ.
Is CancerIQ a funded company?
CancerIQ is a funded company, having raised a total of $23.87M across 6 funding rounds to date. The company's 1st funding round was a Series B of $14M, raised on Jun 01, 2013.
How many employees does CancerIQ have?
As of Dec 31, 2022, the latest employee count at CancerIQ is 78.
What does CancerIQ do?
CancerIQ is engaged in providing software solutions for health systems to enhance access to genomics and oncology innovations. The company operates in the healthcare sector, specifically targeting oncology, genetics, and breast health programs. Its integrated intelligence solution is designed to improve clinical and financial outcomes by addressing workforce challenges and ensuring adherence to medical management recommendations. Tools for risk assessment, patient navigation, and care plan management are offered, alongside connections to telehealth genetic counseling networks. The platform supports providers with clinical decision tools and evidence-based guidelines while enabling seamless integration with electronic health records (EHRs).
Who are the top competitors of CancerIQ?
CancerIQ's top competitors include Tempus, Personalis and Perthera.
What products or services does CancerIQ offer?
CancerIQ offers CancerIQ Platform and Telehealth Genetic Counseling.
Who are CancerIQ's investors?
CancerIQ has 9 investors. Key investors include Amgen, McKesson, Decathlon Capital Partners, Merck Global Health Innovation Fund, and OSF Ventures.